# PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy

> **NCT07349979** · NA · NOT_YET_RECRUITING · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 654 (estimated)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction
- Coronary Artery Disease

## Interventions

- **PROCEDURE:** Percutaneous coronary intervention
- **DRUG:** Guideline-directed medical therapy

## Key facts

- **NCT ID:** NCT07349979
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-30
- **Primary completion:** 2028-01-30
- **Final completion:** 2028-01-30
- **Target enrollment:** 654 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07349979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07349979, "PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07349979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*